Aptar nasal system delivers FDA-approved heart rhythm drug CARDAMYST
Go back to Aptar nasal system delivers FDA-approved heart rhythm drug CARDAMYST| APTARGROUP, Inc. (NYSE: ATR) | Delayed: 124.28 +3.67 (3.04%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $120.61 | 52 Week High | $81.50 | |||
| Open | $121.98 | 52 Week Low | $66.33 | |||
| Day High | $125.05 | P/E | 49.32 | |||
| Day Low | $121.77 | EPS | $2.52 | |||
| Volume | 404,909 | |||||
| (NASDAQ: MIST) | Delayed: 1.27 -0.03 (2.31%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.30 | 52 Week High | $ | |||
| Open | $1.30 | 52 Week Low | $ | |||
| Day High | $1.31 | P/E | N/A | |||
| Day Low | $1.26 | EPS | $ | |||
| Volume | 730,647 | |||||

